Joint PhD Programme for Global Health

LSHTM and Nagasaki University

Overview (MPhil/PhD-Nagasaki-LSHTM)
lshtm-nagasaki logo


The mission of the London School of Hygiene & Tropical Medicine (LSHTM) and Nagasaki University (NU), referred here as the "Partner Universities", is to improve global health through the pursuit of excellence in research, postgraduate education, advanced training and consultancy in international public health and tropical medicine.

The Partner Universities believe that this mission is best achieved through international collaboration. By working together for a common purpose, whilst valuing differences, they can draw on a wider range of human and technical resources to tackle the major global health issues.

Nagasaki University is renowned for its work and research into infectious diseases, and has a long history of collaboration with the London School of Hygiene & Tropical Medicine, which includes a link with their School of Tropical Medicine and Global Health (TMGH). Through working with researchers in the UK and Japan and studying within a community of global researchers, research students will have opportunities to appreciate and celebrate the diversity of cultures and approaches to improving global health. 

This joint PhD programme aims to support the mission of both institutions to improve global health by developing research students who are:

  • competent independent researchers,
  • with expertise in core research concepts, methods and skills, and
  • have key transferable skills, and
  • can work effectively within international collaborative groups  


    Research topics

    NU-LSHTM research projects 2020

    Supervisor(s) Project title
    Prof. Dorothea Nitsch (LSHTM)
    Prof. Tomoya Nishino (NU)
    Does care after acute kidney injury improve outcomes?
    Prof. Mark Rowland (LSHTM)
    Prof. Noboru Minakawa (NU)
    Investigating the impact of insecticide resistance on malaria transmission in sub-Saharan Africa.
    Oliver Brady (LSHTM)
    Prof. Noboru Minakawa (NU)
    Understanding how Aedes aegypti and Ae. albopictus mosquitoes have spread across Asia and its consequences for arboviral disease
    Dr. David Ishola (LSHTM)
    Dr. Kunihiro Ichinose (NU)
    Is there an association between malaria and autoimmune disease in sub-Saharan African patients? An exploratory biomarker-based observational study
    Amaya Bustinduy (LSHTM)
    Kiyoshi Kita (NU)
    Lifting the neglect of female genital schistosomiasis in a Schistosoma haematobium endemic country

    Kathleen M O’Reilly (LSHTM)
    Motoi Suzuki (NU)

    Health and economic impact of a universal rotavirus vaccination programme in Japan
    Dr Matthew Chico (LSHTM)
    Dr Chris Smith (NU)
    Prof Mitsuaki Matsui (NU)
    Investigating the pathways to adverse pregnancy outcomes among women infected with malaria infection and/or sexually transmitted/reproductive tract infections during pregnancy in sub-Saharan Africa
    Sam Wassmer (LSHTM)
    Prof. Kastuyuki Yui (NU)
    Role of lymphocytes in the pathogenesis of and the protection against cerebral malaria
    Dr Rein Houben
    Prof Koya Ariyoshi
    Examining the association respiratory co-infections and chronic cough with and undetected transmission of Mycobacterium tuberculosis
    Alan Dangour (LSHTM)
    Atsushi Hagiwara (NU)
    Impact of climate change on fisheries/aquaculture: fish as nutritional resource for human health in Asia
    Prof. Sinéad Langan
    Prof. Hiroyuki Murota
    Understanding the association between atopic eczema and severe adverse health outcomes
    Wolf-Peter Schmidt (LSHTM)
    Koya Ariyoshi (NU)
    The epidemiology and species diversity of spotted fever group rickettsial infection in India
    Dr Iliatha Papachristou Nadal (LSHTM)
    Dr Abdurrahman Gülbeyaz (NU)
    The development of a mental health awareness digital education package for those at risk of cardiovascular disease. For a Japanese audience.
    Julius Hafalla (LSHTM)
    Shingo Inoue (NU)
    Animal Reservoirs of Human Pathogens in Mindanao, The Philippines
    Prof. Katherine Fielding (LSHTM)
    Prof. Sharon Cox (NU)
    Maintaining engagement to TB regimens utilising digital adherence technology
    Oona Campbell (LSHTM)
    Assistant Prof. Miho Sato (NU)
    A refugee birth cohort: using a unique big dataset to explore the effect of newborn health on subsequent child health and education outcomes, in a vulnerable population facing protracted conflict

    Rosalind Eggo (LSHTM)
    Lay Myint Yoshida (NU)

    Viruses and at-risk populations – the epidemiology and dynamics of respiratory viruses in groups with COPD and asthma
    Antonio Gasparrini (LSHTM)
    Chris Fook Sheng Ng (NU)
    Climate change health impacts and adaptations: drivers and projections
    Antonio Gasparrini (LSHTM)
    Chris Fook Sheng Ng (NU)
    Epidemiological investigation of environmental risk factors using big data methods
    Dr Ai Milojevic (LSHTM)
    Dr Chris Fook Sheng Ng (NU)
    Weather impacts on diarrhoea morbidity and mortality in Dhaka, Bangladesh: empirical study and future climate change projection
    Assistant Prof. Robert Moon (LSHTM)
    Prof. Kiyoshi Kita (NU)
    Understanding the mechanisms behind the virulence of zoonotic malaria parasite Plasmodium knowlesi
    James Logan (LSHTM)Tomonori Hoshi (NU) Development of novel mosquito sampling tools / methods
    Chris Drakeley (LSHTM)
    Richard Culleton (NU)
    The malaria parasites of Bornean primates; prevalence, evolution, phylogenetic relationships & host specificity investigated through whole genome sequencing.
    Dr. Michael Marks (LSHTM)
    Prof. Yasuhiko Kamiya (NU)
    Locally sustainable management of tungiasis in Homa Bay, Kenya along with randomized controlled trial for local treatments
    Heidi Larson (LSHTM)
    Abdurrahman Gülbeyaz (NU)
    Understanding the Differences in the Dynamics of Human Papillomavirus (HPV) Vaccine Refusal in Multiple Countries of Asia and Pacific
    Sanjay Kinra (LSHTM)
    Hirotomo Yamanashi (NU)
    Risk factors of premature cardiovascular and musculoskeletal disease in India and Japan: cross-cohort analysis to improve causal inference
    Colin Sutherland (LSHTM)
    Richard Culleton (NU)
    Understanding artemisinin and partner drug susceptibility in Plasmodium falciparum: genetic crosses with parasites displaying susceptibility phenotypes to identify new resistance genes
    Structure (MPhil/PhD-Nagasaki-LSHTM)


    The PhD Programme is training for research that involves completion of an independent piece of original research. The research will be carried out under the guidance of supervisors from both Partner Universities, with additional support provided by members of an Advisory Board.

    Students will have at least one named supervisor from each Partner University.  A Lead Supervisor will be identified, which will determine the Lead University for the research student.

    Research students will be registered directly for the Joint PhD award, without a preliminary period of registration for the Master of Philosophy (MPhil) degree. Normally, research students will spend at least six months at each of the Partner Universities.  The timing, and possible subdivision, of these periods of residence will be aligned to the needs of the individual research degree study.  There will also be opportunities for research students to undertake research in resource-poor countries around the world.

    The supervisors will prepare progress reports every six months and they will submit these to the Joint Academic Committee (JAC).

    A Qualifying Examination (QE) Panel will review the progress of each research student after 7-11 months of full-time registration (pro rata for part-time registration). Continuation in the Joint PhD programme will be allowed only if the QE Panel is satisfied that the research study and the research student’s progress are sufficiently advanced to indicate that the PhD standard will be reached within the permitted period of registration.

    PhD Research Thesis

    Students complete a written research thesis for the PhD degree which must be written in English with satisfactory literary presentation, and include a full reference list. The thesis should not exceed 100,000 words in length.

    PhD duration

    Research students will be registered at both Partner Universities in early October, enabling them to access the resources of both universities, subject to the relevant regulations, policies and procedures at each university. 

    The minimum, normal and maximum periods of registration for the Joint PhD programme will be as set out below.  

      Minimum Normal Maximum
    Full-time 24 months 36 months 48 months

    Research students will conduct their studies in places approved by the Lead University; normally at the Lead University, the Co-University and one or more approved research site(s).

    Consult the Programme Specification for further details. 

    Fees & funding
    Fees & Funding (LSHTM-Nagasaki)

    The table below shows the fee for each Partner University in their own currency. In order to calculate the full 2020/21 fee for the Joint PhD Programme, you will need to add together both fees (the exchange rate will be confirmed at the time of payment).

    Joint PhD fees     
    LSHTM GBP 2,915 GBP 2,915
    Nagasaki University  JPY 267,900 (subject to change) JPY 267,900 (subject to change)
    Writing-up fee GBP 570 GBP 570

    Application & Admission fees

    • Application Fee: JPY 30,000 (approx. GBP215) 
    • Admission Fee: JPY 282,000 (approx. GBP2,015)

    Applicants who pass the preliminary shortlisting are required to pay  the Nagasaki University application fee. Please refer to the application guidance for payment instructions.

    The admission fee is for successful candidates who are offered a place on the Joint programme. Details on how to pay will be given in the offer of admission letter.

    Funding opportunity

    Nagasaki University was awarded the Doctoral Program for World-leading Innovative & Smart Education (WISE), offered by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) in 2018. The Nagasaki University WISE Programme for Global Health established a financial support scheme to provide a stipend for the selected grantee and a research grant for the grantee’s supervisory team to support their research in Global Health. Students accepted onto the Joint PhD Programme can apply to the Doctoral Program for World-leading Innovative & Smart Education (WISE).

    Applicants who are selected as a WISE Programme Student will receive a stipend (last year this was approx. JPY 200,000 per month ), and the supervisory team will receive a small research grant to support the PhD research (last year this was approx. JPY 2,000,000 per annum). The amount maybe subject to change for this year but further information can be found on the Nagasaki University Wise Programme website.

    The WISE programme does not cover tuition or admission fees. For further information about living costs in London, please refer to our Study with us section, and in particular the Cost of living section.

    For WISE funding enquiries, please email to:

    Entry requirements
    Entry Requirements (PhD-Nagasaki-LSHTM)

    Academic requirements

    The programme (and the funding award) is open to any candidate who can satisfy the entrance requirements.

    A student must normally satisfy entrance requirements as follows:

    The normal minimum entrance qualification for registration is at least one of the following:

    • a master’s degree in a subject appropriate to the course of study to be followed (recommended)
    • a qualification appropriate to the course of study to be followed, in medicine, dentistry or veterinary studies
    • an upper second-class honours degree from a UK or Japanese university, or an overseas qualification of an equivalent standard, in a relevant subject.

    Desirable but not essential is knowledge of the Japanese language and an awareness of Japanese culture AND evidence of an aptitude for research.

    English language requirements

    If English is not your first language, you will need to meet these requirements: Band B

    Please see our English Language Requirements FAQs for information.

    How to apply
    How to apply (LSHTM-Nagasaki)

    The application deadline is 19 January 2020, 23:59 GMT (extended from 17 January 2020). 

    Applying for a doctoral degree can be a lengthy process and requires some preparation. Please read the following two documents before you apply to ensure you send in a completed application with the correct supporting documents.

    To apply:

    • select a project from the research topic list
    • contact the research topic supervisor for an informal chat
    • Submit your application 
    Partner universities
    NU and LSHTM

    Nagasaki University (NU)

    The history of Nagasaki University goes all the way back to 1857 when Dutch naval surgeon Dr Pompe established Igaku Denshusho, which was the oldest medical school in Japan. Although Nagasaki Medical College Igaku Denshusho was completely demolished in 1945 by the atomic bomb, it has now grown into an important university that comprises nine faculties and seven graduate schools (Global Humanities and Social Science, Education, Economics, Medicine, Dentistry, Pharmaceutical Sciences, Engineering, Environmental Studies, Fisheries and Tropical Medicine and Global Health), affiliated hospitals, libraries, the Institute of Tropical Medicine and the Atomic Bomb Disease Institute.

    Nagasaki University is the only university in Japan with Institute of Tropical Medicine (NEKKEN) since 1947, and is considered the leading university in the field of Tropical Medicine and Global Health in Japan, with overseas research stations in Kenya and Vietnam.

    London School of Hygiene & Tropical Medicine (LSHTM)

    Founded in 1899, LSHTM is widely recognised as a world-leading centre for research and postgraduate education in public and global health, with over 4,000 students and more than 1,000 staff working in over 100 countries across the world.

    LSHTM is working closely with partners in the UK and worldwide to address contemporary and future critical health challenges. It has a diverse and truly global community dedicated to quality cross-disciplinary research and is involved at every stage of the research pipeline, from basic science all the way through to evaluation of health interventions, providing a firm foundation of evidence for improving health.

    Its mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice.